In this MedPage Today video, Taylor Brooks, MD, of the Cleveland Clinic Cancer Institute, discusses real-world survival ...

The Phase 1b/2 SCLC trial and Phase 2 VIRO-25 trial are actively enrolling in dose escalation cohorts with an aim to optimize efficacy, safety, and tolerability of Olvi-Vec. The trials are being ...

The U.S. Food and Drug Administration (FDA) approved six new therapies in December 2025 for blood cancers, prostate cancer, ...

Please provide your email address to receive an email when new articles are posted on . It is a truism that, “If you operate, you will have complications.” Wise surgeons plan ahead to avoid ...

In patients with relapsed or refractory systemic lupus erythematosus, allogeneic CAR-NK cell therapy may offer a safe ...

At ASH 2025, investigators reported early results from the first-in-human phase 1 inMMyCAR study evaluating KLN-1010, an ...

Refractory angina is an increasingly prevalent clinical syndrome characterized by ongoing ischaemic symptoms despite optimal medical management in patients for whom traditional revascularization is ...

Andrew Yee, MD, introduces the discussion by reviewing treatment challenges, patient education, and decision-making in relapsed/refractory multiple myeloma.

Refractory dry eye in patients with systemic comorbidities can be challenging to manage because the underlying condition or ...

An Arizona patient with synovial sarcoma has received a new immune cell therapy. Officials at HonorHealth Research Institute ...

Please provide your email address to receive an email when new articles are posted on . Case history: A 72-year-old patient underwent cataract surgery using the Crystalens accommodating lens implant ...

ALISO VIEJO, Calif.--(BUSINESS WIRE)-- WaveTec Vision, the leader in wavefront-guided custom cataract™ surgery, announced today that its ORange ® intraoperative wavefront aberrometer has been shown to ...